US Patent Issued to Annexon on Jan. 27 for "Anti-complement factor C1q antibodies and uses thereof" (California Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,522, issued on Jan. 27, was assigned to Annexon Inc. (Brisbane, Calif.).

"Anti-complement factor C1q antibodies and uses thereof" was invented by Arnon Rosenthal (Woodside, Calif.) and Michael Leviten (Emerald Hills, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides anti-C1q antibodies and methods of using the same."

The patent was filed on Feb. 16, 2023, under Application No. 18/110,574.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12534522&OS...